Trial Profile
Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2017
Price :
$35
*
At a glance
- Drugs Idronoxil (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Novogen
- 17 Nov 2017 According to a Kazia Therapeutics media release, Novogen changed its name to Kazia Therapeutics.
- 24 Dec 2010 New trial record